Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality DOI Creative Commons
Jo Ishizawa,

Sarah F. Zarabi,

R. Eric Davis

et al.

Cancer Cell, Journal Year: 2019, Volume and Issue: 35(5), P. 721 - 737.e9

Published: May 1, 2019

The mitochondrial caseinolytic protease P (ClpP) plays a central role in protein quality control by degrading misfolded proteins. Using genetic and chemical approaches, we showed that hyperactivation of the selectively kills cancer cells, independently p53 status, selective degradation its respiratory chain substrates disrupts structure function, while it does not affect non-malignant cells. We identified imipridones as potent activators ClpP. Through biochemical studies crystallography, show bind ClpP non-covalently induce proteolysis diverse structural changes. Imipridones are presently clinical trials. Our findings suggest general concept inducing cell lethality through activation proteolysis.

Language: Английский

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 DOI Creative Commons
Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson

et al.

Cell Death and Differentiation, Journal Year: 2018, Volume and Issue: 25(3), P. 486 - 541

Published: Jan. 23, 2018

Over the past decade, Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for definition and interpretation of cell death from morphological, biochemical, functional perspectives. Since field continues to expand novel mechanisms that orchestrate multiple pathways are unveiled, we propose an updated classification subroutines focusing mechanistic essential (as opposed correlative dispensable) aspects process. As provide molecularly oriented definitions terms including intrinsic apoptosis, extrinsic mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic death, NETotic lysosome-dependent autophagy-dependent immunogenic cellular senescence, mitotic catastrophe, discuss utility neologisms refer highly specialized instances these processes. The mission NCCD is a widely accepted nomenclature in support continued development field.

Language: Английский

Citations

5365

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies DOI
Jérôme Galon, Daniela Bruni

Nature Reviews Drug Discovery, Journal Year: 2019, Volume and Issue: 18(3), P. 197 - 218

Published: Jan. 4, 2019

Language: Английский

Citations

2639

Targeting apoptosis in cancer therapy DOI
Benedito A. Carneiro, Wafik S. El‐Deiry

Nature Reviews Clinical Oncology, Journal Year: 2020, Volume and Issue: 17(7), P. 395 - 417

Published: March 23, 2020

Language: Английский

Citations

1942

BCL-2 family proteins: changing partners in the dance towards death DOI Creative Commons
Justin Kale, Elizabeth J. Osterlund, David W. Andrews

et al.

Cell Death and Differentiation, Journal Year: 2017, Volume and Issue: 25(1), P. 65 - 80

Published: Nov. 17, 2017

The BCL-2 family of proteins controls cell death primarily by direct binding interactions that regulate mitochondrial outer membrane permeabilization (MOMP) leading to the irreversible release intermembrane space proteins, subsequent caspase activation and apoptosis. affinities relative abundance dictate predominate between anti-apoptotic pro-apoptotic MOMP. We highlight core mechanisms regulation MOMP with an emphasis on how govern fate. address critical importance both concentration show differences in either can greatly change outcome. Further, we explain using full-length (versus truncated versions or peptides) parse out family. Finally, discuss post-translational modifications differing intracellular localizations alter apoptosis proteins. Successful therapeutic intervention human disease requires understanding factors mediate major cells.

Language: Английский

Citations

1299

BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis DOI Open Access
Kate McArthur, Lachlan Whitehead, John M. Heddleston

et al.

Science, Journal Year: 2018, Volume and Issue: 359(6378)

Published: Feb. 22, 2018

Mitochondrial apoptosis is mediated by BAK and BAX, two proteins that induce mitochondrial outer membrane permeabilization, leading to cytochrome c release activation of apoptotic caspases. In the absence active caspases, DNA (mtDNA) triggers innate immune cGAS/STING pathway, causing dying cells secrete type I interferon. How cGAS gains access mtDNA remains unclear. We used live-cell lattice light-sheet microscopy examine network in mouse embryonic fibroblasts. found after BAK/BAX loss, broke down large pores appeared membrane. These macropores allowed inner herniate into cytosol, carrying with it matrix components, including genome. Apoptotic caspases did not prevent herniation but dismantled cell suppress mtDNA-induced signaling.

Language: Английский

Citations

792

From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors DOI
Avi Ashkenazi, Wayne J. Fairbrother, Joel D. Leverson

et al.

Nature Reviews Drug Discovery, Journal Year: 2017, Volume and Issue: 16(4), P. 273 - 284

Published: Feb. 17, 2017

Language: Английский

Citations

790

Drugging the 'undruggable' cancer targets DOI
Chi V. Dang, E. Premkumar Reddy, Kevan M. Shokat

et al.

Nature reviews. Cancer, Journal Year: 2017, Volume and Issue: 17(8), P. 502 - 508

Published: June 23, 2017

Language: Английский

Citations

770

Emerging connectivity of programmed cell death pathways and its physiological implications DOI
Sammy Bedoui, Marco J. Herold, Andreas Strasser

et al.

Nature Reviews Molecular Cell Biology, Journal Year: 2020, Volume and Issue: 21(11), P. 678 - 695

Published: Sept. 1, 2020

Language: Английский

Citations

723

BCL-2 family isoforms in apoptosis and cancer DOI Creative Commons

Chloe Warren,

Michelle W. Wong‐Brown, Nikola A. Bowden

et al.

Cell Death and Disease, Journal Year: 2019, Volume and Issue: 10(3)

Published: Feb. 21, 2019

Abstract The BCl-2 family has long been identified for its role in apoptosis. Following the initial discovery of BCL-2 context B-cell lymphoma 1980s, a number homologous proteins have since identified. members Bcl-2 are designated as such due to their homology (BH) domains and involvement apoptosis regulation. BH facilitate members’ interactions with each other can indicate pro- or anti-apoptotic function. Traditionally, these categorised into one three subfamilies; anti-apoptotic, BH3-only (pro-apoptotic), pore-forming ‘executioner’ (pro-apoptotic) proteins. Each distinct pattern activation, localisation response cell death survival stimuli. All vary across stress types, developmental stage, this cause delineation roles members. Added complexity is presence relatively uncharacterised isoforms many There gap our knowledge regarding function isoforms. domain status not always predictive indicative protein function, several important sequences, which contribute apoptotic activity While therapeutic strategies targeting constantly under development, it imperative that we understand molecules, attempting target. This review, discusses current With significant improvements potential splicing therapies, begin distinctions family, limited just mechanisms control, but outside

Language: Английский

Citations

576

A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity DOI
Sajid Khan, Xuan Zhang, Dongwen Lv

et al.

Nature Medicine, Journal Year: 2019, Volume and Issue: 25(12), P. 1938 - 1947

Published: Dec. 1, 2019

Language: Английский

Citations

503